[1] LUDWIG J,VIGGIANO T R,MCGILL D B,et al.Nonalcoholic steatohepatitis:Mayo clinic experiences with a hitherto unnamed disease[C]//Mayo Clinic Proceedings.1980,55(7):434-438.
[2] PETTA S,MURATORE C,CRAXÌ A.Non-alcoholic fatty liver disease pathogenesis:the present and the future[J].Digestive and Liver Disease,2009,41(9):615-625.
[3] GRATTAGLIANO I,DE BARI O,BERNARDO T C,et al.Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation[J].Clinical Biochemistry,2012,45(9):610-618.
[4] NARASIMHAN S,GOKULAKRISHNAN K,SAMPATHKUMAR R,et al.Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes[J].Clinical Biochemistry,2010,43(10/11):815-821.
[5] BECK M A.Selenium and host defence towards viruses[J].Proceedings of the Nutrition Society,1999,58(3):707-711.
[6] OZAKI M,DESHPANDE S S,ANGKEOW P,et al.Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis
in vivo[J].The FASEB Journal,2000,14(2):418-429.
[7] MALIKEN B D,NELSON J E,KLINTWORTH H M,et al.Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease[J].Hepatology,2013,57(5):1806-1813.
[8] CHO A S,JEON S M,KIM M J,et al.Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice[J].Food and Chemical Toxicology,2010,48(3):937-943.
[9] BASSOLI B K,CASSOLLA P,BORBA-MURAD G R,et al.Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test:effects on hepatic glucose release and glycaemia[J].Cell Biochemistry and Function,2008,26(3):320-328.
[10] 梁秀慈,孟文,钟英丽,等.绿原酸对高脂乳诱导小鼠胰岛素抵抗形成的影响[J].中国药理学通报,2013,29(5):654-658.
[11] LI S Y,CHANG C Q,MA F Y,et al.Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-α in golden hamsters fed on high fat diet[J].Biomedical and Environmental Sciences,2009,22(2):122-129.
[12] HUANG K,LIANG X C,ZHONG Y L,et al.5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription[J].Journal of the Science of Food and Agriculture,2015,95(9):1903-1910.
[13] SATO Y,ITAGAKI S,KUROKAWA T,et al.
In vitro and
in vivo antioxidant properties of chlorogenic acid and caffeic acid[J].International Journal of Pharmaceutics,2011,403(1/2):136-138.
[14] MUBARAK A,HODGSON J M,CONSIDINE M J,et al.Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice[J].Journal of Agricultural and Food Chemistry,2013,61(18):4371-4378.
[15] BONITA J S,MANDARANO M,SHUTA D,et al.Coffee and cardiovascular disease:
in vitro,cellular,animal,and human studies[J].Pharmacological Research,2007,55(3):187-198.
[16] WANG Z,CLIFFORD M N.Comparison of the profiles of chlorogenic acids and their derivatives from three Chinese traditional herbs by LC-MS
n[J].Acta Pharmaceutica Sinica,2008,43(2):185-190.
[17] CLIFFORD M N.Chlorogenic acids and other cinnamates:nature,occurrence and dietary burden[J].Journal of the Science of Food and Agriculture,1999,79(3):362-372.
[18] 黄继汉,黄晓晖,陈志扬,等.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072.
[19] KASS G E N.Mitochondrial involvement in drug-induced hepatic injury[J].Chemico-Biological Interactions,2006,163(1/2):145-159.
[20] FELDSTEIN A E,CANBAY A,GUICCIARDI M E,et al.Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice[J].Journal of Hepatology,2003,39(6):978-983.
[21] 梅玫,陆伟.细胞色素P450 2E1在脂肪性肝病中致病作用研究进展[J].实用肝脏病杂志,2007,10(1):61-64.
[22] LI Z Z,BERK M,MCINTYRE T M,et al.The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity[J].Hepatology,2008,47(5):1495-1503.
[23] ZHANG W,KUDO H,KAWAI K,et al.Tumor necrosis factor-α accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease[J].Biochemical and Biophysical Research Communications,2010,391(4):1731-1736.
[24] HUI J M,HODGE A,FARRELL G C,et al.Beyond insulin resistance in NASH:TNF-α or adiponectin?[J].Hepatology,2004,40(1):46-54.
[25] DAUGHERITY E K,BALMUS G,AL SAEI A,et al.The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease[J].Cell Cycle,2012,11(10):1918-1928.
[26] OLTVAL Z N,MILLIMAN C L,KORSMEYER S J.Bcl-2 heterodimerizes
in vivo with a conserved homolog,Bax,that accelerates programed cell death[J].Cell,1993,74(4):609-619.
[27] RIBEIRO P S,CORTEZ-PINTO H,SOLÁ S,et al.Hepatocyte apoptosis,expression of death receptors,and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients[J].The American Journal of Gastroenterology,2004,99(9):1708-1717.
[28] ELSHARKAWY A M,MANN D A.Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis[J].Hepatology,2007,46(2):590-597.
[29] ARUNKUMAR N,LIU C H,HANG H Y,et al.Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation[J].Cellular & Molecular Immunology,2013,10(4):360-372.
[30] QURESHI K,ABRAMS G A.Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2007,13(26):3540-3553.
[31] HONG F,KIM W H,TIAN Z G,et al.Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver:involvement of induction of Bcl-2 and Bcl-xL proteins[J].Oncogene,2002,21(1):32-43.
[32] 杨斌,丘岳,王柳萍,等.广西山银花绿原酸体外抗炎作用及分子机制研究[J].中国药理学通报,2009,25(4):542-545.
[33] 胡健萍.代谢综合征小鼠模型的建立及中药复方干预[D].硕士学位论文.北京:北京协和医学院,2009.
